COLUMBIA — South Carolina women's basketball guard Raven Johnson sat alongside Gamecocks safety Nick Emmanwori as he was selected No. 35 overall by the Seattle Seahawks in the 2025 NFL Draft.

The Gamecocks likely would have lost if not for superstar sophomore MiLaysia Fulwiley, who carried them on offense when many other players were struggling to create offense. Fulwiley finished the ...

Rocket Pharmaceuticals, Inc.’s (NASDAQ:RCKT) prospects have taken a significant hit on the company being forced to halt research on its experimental gene therapy for Danon Disease. The decision ...

Shares of Rocket Pharmaceuticals RCKT plunged 62.8% on Tuesday after the company announced a patient death in a pivotal phase II study evaluating its investigational gene therapy candidate, RP ...

The U.N.’s libel has led to bloodshed. The blood of a beautiful young couple, Yaron Lischinsky and Sarah Lynn Milgrim, who worked together at the Israeli Embassy in Washington, D.C. The couple ...

Fulwiley scored 16 points in the second half, including a highlight reel behind-the-back layup, to hold the No. 4 Terrapins (25-8) at bay. Start the day smarter. Get all the news you need in your ...

The U.N.’s libel has led to bloodshed. The blood of a beautiful young couple, Yaron Lischinsky and Sarah Lynn Milgrim, who worked together at the Israeli Embassy in Washington, D.C. The couple were ...

Rocket Pharmaceuticals acknowledged the death of a patient in a pivotal trial assessing its Danon disease gene therapy candidate RP-A501, a study that the FDA has placed on clinical hold.

Image credit: Andrii Yalanskyi / Shutterstock. A patient has died in a pivotal Phase II trial of Rocket Pharmaceuticals’ gene therapy for Danon disease after suffering a serious adverse event (AE).